Medtronic MDT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Medtronic’s reported figures.
Based on trailing twelve months.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's return on equity?
- Medtronic (MDT) reported return on equity of 9.8% in Q1 2026.
- How has Medtronic's return on equity changed year-over-year?
- Medtronic's return on equity increased by 3.8% year-over-year, from 9.5% to 9.8%.
- What is the long-term trend for Medtronic's return on equity?
- Over 5 years (2021 to 2026), Medtronic's return on equity has grown at a 6.4% compound annual growth rate (CAGR), from 28.5% to 38.8%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.